ASN95 -- Selected abstracts: Diabetic Renal Disease

Sun. Nov. 5 1995

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Mechanisms of progression

Program number 99 Board# S99 at 10:45 A.M.
* Non-insulin dependent diabetes with low-renin hypertension: Renal responses to ACE-inhibition. J.M. de Oliveira, D.A. Price, N.D.L. Fisher and N.K. Hollenberg. - Boston, MA.

Program number 108 Board# S108 at 10:45 A.M.
* Urinary transforming growth factor beta1 and progression of glomerular diseases. E. Honkanen, A-M. Teppo, T. Tornroth and C.Gronhagen-Riska. - Helsinki, Finland.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Hemodialysis methods

Program number 211 Board# S211 at 10:45 A.M.
* Depletion of advanced glycated endproducts in uremic serum and dialysis fluid by an age-binding lysozyme-matrix; a potential adjunct therapy for uremia? T. Mitsuhashi, Y.M. Li, S. Fishbane and H. Vlassara. - Manhasset and Mineola, NY.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Diabetes mellitus: In vivo mechanisms

Program number 406 Board# S406 at 10:45 A.M.
* Interactions of renin-angiotensin and kallikrein-kinin systems in the diabetic kidney. J.P. Vora, T.T. Oyama, M.M. Thompson and S. Anderson. - Portland, OR.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Diabetes mellitus

Program number 434 Board# S434 at 10:45 A.M.
* Progression of overt diabetic nephropathy: Role of metabolic control. H. Mulec, G. Blohme, B. Grande and S. Bjorck. - Goteborg and Trollhattan, Sweden.

Program number 435 Board# S435 at 10:45 A.M.
* Smoking - a major predictor of nephropathy in newly diagnosed type II diabetes. C. Keller, K. Bergis and E. Ritz. - Heidelberg and Mergentheim, Germany.

Program number 436 Board# S436 at 10:45 A.M.
* Late complications in non-insulin dependent diabetes: A multivariate logistic analysis of risk factors in 2500 patients. V. Gambara, P. Ruggenenti, G. Vigano, a. Perna and G. Remuzzi. - Bergamo, Italy.

Program number 437 Board# S437 at 10:45 A.M.
* Correlates of diabetic and non-diabetic renal disease in NIDDM. S. Kahn, V. Sehgal, G.B. Appel and V. D'Agati. - Newyork, NY.

Program number 442 Board# S442 at 10:45 A.M.
* The ACE gene polymorphism in patients with diabetic nephropathy. U. Barnas, A. Schmidt, A. Illievich, D. Rabensteiner, R. Prager and G. Mayer. - Vienna, Austria.

Program number 443 Board# S443 at 10:45 A.M.
* Short-term comparison of ACE inhibition versus calcium channel blockade in African-Americans with type II diabetes mellitus and nephropathy. O. Campbell, M. Cua, M. Parham, W. You, E. Macon and A. Guasch. - Atlanta, Ga.

Program number 444 Board# S444 at 10:45 A.M.
* Long term effect of captopril on kidney function in normotensive insulin dependent diabetic patients with diabetic nephropathy. E. Hommel, B. Jensen and H-H. Parving. - Copenhagen, Denmark.

Program number 445 Board# S445 at 10:45 A.M.
* The dopaminuric response to high salt diet is attenuated both in insulin-dependent diabetes and in offspring of borderline hypertensive parents. S. Rudberg, C. Lemne, B. Persson, A. Krekula, U. De faire and A. Aperia. - Stockholm, Sweden.

Program number 446 Board# S446 at 10:45 A.M.
* The effects of salt-loading on blood pressure and arterial distensibility, And the relation with the renal blood flow response to angiotensin-II in IDDM. J. Lambert, R. Pijpers, F.J. Vittersum, M. Aarsen, A.J.M. Donker and C.D.A. Stehouwer. - Amsterdam, The Netherlands.

Program number 447 Board# S447 at 10:45 A.M.
* Hyporeninemia is associated with erythropoietin deficiency in type I diabetic patients. S. Donnelly. - Toronto, Canada.

Program number 448 Board# S448 at 10:45 A.M.
* Erythrocyte Na+/Li+ and Na+/H+ countertransports in hypertensive NIDDM subjects. The effects of insulin and anti-H treatment. M.Giordano, M. Canessa, P. Castellino and R.A. Defronzo. - San Antonio, TX.

Program number 450 Board# S450 at 10:45 A.M.
* Erythropoietin delays the onset of uremia in anemic azotemic diabetic predialysis patients. C.D. Brown, Z.H. Zhao, L.L. Thomas and E.A. Friedman. - Brooklyn, NY.

Program number 665 at 4:15
* Renal production of TGF-beta is increased in diabetic patients. K. Sharma, T. McGowen, F.N. Ziyadeh, B. Kurnik, P. Kurnik and L. Weisberg. - Philadelphia, PA and Camden, NJ.

Program number 666 at 4:30
* Glomerular structure in long term type II diabetes with and without microalbuminuria. M.E. Pagtalunan, P.L. Miller, R.G. Nelson, B.D. Myers, N. Coplon, S. Jumping-Eagle and T.W. Meyer. - Palo Alto, CA and Phoenix, AZ.

Program number 667 at 4:45
* Cyclosporine nephrotoxicity in insulin-dependent diabeticpatients: An eight year follow-up. H-H. Parving, L. Tarnow, F.S. Nielsen, P. Rossing, T. Mandrup-Poulsen and J. Nerup. - Gentofte, Denmark.

Program number 670 at 5:30
* Efficacy of captopril in normotensive diabetic patients with microalbuminuria--8 years follow-up. E.R. Mathiesen, E. Hommel, U.M. Smidt and H-H. Parving. - Copenhagen, Denmark.

Mon. Nov. 6 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Renal hemodynamics II

Program number 737 Board# M6 at 10:00 A.M.
* Sodium restriction exacerbates renal hemodynamic abnormalities in early diabetes. J.A. Miller. - Toronto,Canada.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Hemodynamic/cardiovascular relationships of dialysis/end-stage renal disease

Program number 797 Board# M66 at 10:00 A.M.
* Increased atherogenic risk of diabetic patients undergoing hemodialysis: role of modified, triglyceride-rich lipoproteins. A. Kramer-Guth, M. Schomig, M. Keller, M.W. Baumstark, J. Thiery, W. Marz, P. Schollmeyer and C. Wanner. - Munich and Wurzburg, Germany.

Program number 892 Board# M161 at 10:00 A.M.
* Predictors of short-term mortality in diabetic hemodialysis patients. R.A. Ward, M.E. Brier, P. Deoreo, K.M. Erbeck, R.J. Hamburger and B.A.Smith. - Louisville, Ky; Cleveland, OH and Indianapolis, IN.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Nutrition and dialysis

Program number 990 Board# M259 at 10:00 A.M.
* Blood glucose determination in diabetic hemodialysis patients. C.A. Frankenburg, J.A. Hasbargen and R.L. Roudebush. - Indianapolis, IN.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Modeling in dialysis: Techniques and applications II

Program number 1012 Board# M281 at 10:00 A.M.
* Plasminogen activator inhibitor-1 and peritoneal transport in diabetic and non-diabetic dialysis patients. N.K. Wadhwa, J-J. Lin, L. Parton and G. Bereket. - Stony brook, NY.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Clinical transplantation: Immunosuppressive treatment

Program number 1123 Board# M392 at 10:00 A.M.
* Prednisone withdrawal in diabetic renal allograft recipients. a.S. Bains, S. Hariharan, V.R. Peddi, T.J. Schroeder, P.A. Weiskittel and M.R. First. - Cincinnati, OH.

Program number 1144 Board# M413 at 10:00 A.M.
* Combined pancreas-kidney transplantation Is associated with long-term improvement in cardiac function. A.O. Gaber, S. El-Gebely, P. Sugathan, D.K. Hathaway, D.S. Elmer, R. McCulley and B. Burlew. - Memphis, TN.

4:00 P.M. ---minisymposia--- San Diego Conv Ctr Rm 2
Diabetic nephropathy

Program number 1340 at 4:45
* Heterogeneity of diabetic renal lesions in non-proteinuric type II (NIDDM) diabetic patients. P. Fioretto, M. Mauer, E. Brocco, M. Velussi, Muollo, M. Sambataro, g. Crepaldi, B. Baggio, A. Borsattiand R. Nosadini. - Padua and Sassari, Italy and Minneapolis, MN.

Program number 1344 at 5:45
* Effect of nondihydropyridine calcium antagonists onprogressionof nephropathy from noninsulin dependent diabetes: A five year follow-up study. G.L. Bakris, J.B. Copley, N. Vicknair and S. Leurgans. - New Orleans, LA and Chicago, IL.

Tue. Nov. 7 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Electrolyte and acid-base disorders

Program number 1491 Board# T41 at 10:00 A.M.
* Diabetic hyperkalemia -- body composition analysis. M.L. Graber, W. Shreeve, R. Ma and R.N. Pierson, Jr. - Northport and Upton, NY.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Hypertension: Clinical II

Program number 1523 Board# T73 at 10:00 A.M.
* Acute renal hemodynamic changes associated with calcium antagonists persist for years. a.C. Smith, N. Vicknair, J.B. Copley, J. Yi and G.L.Bakris. - New Orleans, LA and Chicago, IL.

Program number 1538 Board# T88 at 10:00 A.M.
* Captopril and doxazosin induce similar changes in renal hemodynamics in hypertensive patients with insulin dependent diabetes mellitus. E. Svarstad, E. Gerdts, P. Omvik, B.M. Iversen J. Ofstad. - Bergen, Norway.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Clinical transplantation I

Program number 1807 Board# T357 at 10:00 A.M.
* High prevalence of undiagnosed glucose intolerance and diabetes in hypercholesterolemic renal transplant recipients. M.S. Markell, N. Sumrani, Y. Sarn, E. Toro, J.H. Hong, B.G. Sommer and E.A. Friedman. - Brooklyn, NY.

4:00 P.M. ---Free communications--- San Diego Conv Ctr Rm 5ab
Morbidity and mortality in end-stage renal disease patients

Program number 2107 at 5:00
* Survival of type II diabetic native American Indians on hemodialysis Is better than caucasians. C.A.I. Hirata-Dulas, D.C. Dahl, K. Modi, J.Z. Ma, A.J. Collins and W.F. Keane. - Minneapolis, MN.

4:00 P.M. ---Free Communications--- San Diego Conv Ctr Rm 17a
Clinical transplantation II

Program number 2140 at 4:15
* Kidney/pancreas transplant versus kidney transplant alone. C.L. Manske and W. Thomas. - Minneapolis, MN.

Wed. Nov. 8 1995

10:00 A.M. ---Free Communications--- San Diego Conv Ctr Rm 4
Renin angiotensin system: Polymorphism and renal disease

Program number 2249 at 10:30
* The m235t variant of the angiotensinogen gene and nephropathy in type 2 diabetes. S. Schmidt, K. Strojek, W. Grzeszczak, D. Ganten and E. Ritz. - Heidelberg and berlin, Germany.

Use BACK arrow on your browser (faster) or click here to go back to ASN95 main page

UP Click on ARROW for HDCN Home Page.